Ayurveda management of ARTAVA KSHAYA w.s.r to PCOS

Phase 2

Not yet recruiting

• Conditions: Health Condition 1: N91- Absent, scanty and rare menstruation

• Registration Number: CTRI/2024/05/067664
• Lead Sponsor: DrBharathi K S

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 27 May 2024

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

(1) Female Patients between the age of 18-35 years.

(2) Patients diagnosed for PCOS.

(3) Both married and unmarried women.

(4) Infrequent menses at interval longer than 35 days.

(5) Spotting, Scanty bleeding.

(6) Yoni Vedana ( pain in vagina)

Exclusion Criteria

(1) Patient having congenital anomalies of genital organs.

(2) Primary amenorrhoea.

(3) Patient already on Hormonal therapy.

(4) Lactating women.

(5) Trauma to ovaries.

(6) Androgen secreting tumours and adrenal hyperplasia.

(7) Woman having Hb <8gm%

(8) Hyperprolactinemia, Cushing syndrome

(9)Woman having other systemic disorders like- TB, DM, Hypertension, Hypo/hyperthyroidism, HIV, HbsAg, Malignancy.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Irregular cycle <br/ ><br>Scanty bleeding <br/ ><br>Pain in vagina <br/ ><br> <br/ ><br>Number of pads used per day <br/ ><br>Duration of inter-menstrual period <br/ ><br>Interval of menstrual phase <br/ ><br>USG changesTimepoint: assessment done before treatment(1st day),after treatment(12th week) & after follow up(16th week)

Secondary Outcome Measures

Name	Time	Method
Irregular cycle <br/ ><br>Scanty bleeding <br/ ><br>Pain in vagina <br/ ><br> <br/ ><br>Number of pads used per day <br/ ><br>Duration of inter-menstrual period <br/ ><br>Interval of menstrual phase <br/ ><br>USG changesTimepoint: assessment done before treatment(1stday),after treatment(12th week) & after follow up(16th week)